Mindful Media/E+ via Getty Images Investment Thesis GE HealthCare Technologies (NASDAQ: GEHC ) was spun off from General Electrics ( GE ) in December last year and went public. The company has performed exceptionally well, with shares up over 30% in a little less than 3 months. The company operates in an attractive end market that continues to see increasing demand. Despite facing a volatile macro environment, its latest earnings result showed solid top-line growth and strong profitability with upbeat guidance. Even after the recent rally, the company’s valuation is still attractive, with multiples below other healthcare peers. I believe the company still has meaningful upside potential therefore I rate it as a buy. Data by YCharts Why GE HealthCare? GE HealthCare is an Illinois-based company that specializes in medical technology, pharmaceutical diagnostics, and digital solutions. The company generates most of its revenue from imaging and ultra-sound products, which currently accounts for roughly 75% of total revenue. The remaining revenues are generated from services such as financial solutions and clinical networking solutions, and more. There are currently over 4 million of the company’s products installed globally, helping over 2 billion patients in 2022 alone. The TAM (total addressable market) […]
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
